Skip to main content
SpringerLink
Log in

26-Year-Old Female with Worsening Psoriasis Who Is Planning Pregnancy

  • Chapter
  • First Online:
Book cover Clinical Cases in Psoriasis

Part of the book series: Clinical Cases in Dermatology ((CLIDADE))

  • 498 Accesses

Abstract

A 26-year-old woman presents with worsening diffuse-body psoriasis while on a regimen of topical steroids and ultraviolet B phototherapy. She qualifies for treatment with biologics, but she is also planning pregnancy. Certolizumab pegol, a novel tumor necrosis factor inhibitor that does not undergo transplacental transport, is considered the safest biologic with regards to fetal outcomes. After counseling on the risks and benefits of biologic therapy, the patient chose to switch her regimen to certolizumab pegol prior to becoming pregnant.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 69.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Murase JE, Chan KK, Garite TJ, Cooper DM, Weinstein GD. Hormonal effect on psoriasis in pregnancy and post partum. Arch Dermatol. 2005;141(5):601–6.

    Article  CAS  Google Scholar 

  2. Ceovic R, Mance M, Bukvic mokos Z, Svetec M, Kostovic K, Stulhofer buzina D. Psoriasis: female skin changes in various hormonal stages throughout life—puberty, pregnancy, and menopause. Biomed Res Int. 2013;2013:571912.

    Article  Google Scholar 

  3. Vena GA, Cassano N, Bellia G, Colombo D. Psoriasis in pregnancy: challenges and solutions. Psoriasis (Auckl). 2015;5:83–95.

    CAS  Google Scholar 

  4. Cohen-Barak E, Nachum Z, Rozenman D, Ziv M. Pregnancy outcomes in women with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2011;25(9):1041–7.

    Article  CAS  Google Scholar 

  5. Lima XT, Janakiraman V, Hughes MD, Kimball AB. The impact of psoriasis on pregnancy outcomes. J Invest Dermatol. 2012;132(1):85–91.

    Article  CAS  Google Scholar 

  6. Trivedi MK, Vaughn AR, Murase JE. Pustular psoriasis of pregnancy: current perspectives. Int J Women’s Health. 2018;10:109–15.

    Article  CAS  Google Scholar 

  7. Chi CC, Lee CW, Wojnarowska F, Kirtschig G. Safety of topical corticosteroids in pregnancy. Cochrane Database Syst Rev. 2009;3:CD007346.

    Google Scholar 

  8. Park KK, Murase JE. Narrowband UV-B phototherapy during pregnancy and folic acid depletion. Arch Dermatol. 2012;148(1):132–3.

    Article  CAS  Google Scholar 

  9. Mason RJ, Thomson AW, Whiting PH, et al. Cyclosporine-induced fetotoxicity in the rat. Transplantation. 1985;39(1):9–12.

    CAS  PubMed  Google Scholar 

  10. Paziana K, Del Monaco M, Cardonick E, et al. Ciclosporin use during pregnancy. Drug Saf. 2013;36(5):279–94.

    Article  CAS  Google Scholar 

  11. Johansen CB, Jimenez-Solem E, Haerskjold A, Sand FL, Thomsen SF. The use and safety of TNF inhibitors during pregnancy in women with psoriasis: a review. Int J Mol Sci. 2018;19(5):pii: E1349.

    Google Scholar 

  12. Raja H, Matteson EL, Michet CJ, Smith JR, Pulido JS. Safety of tumor necrosis factor inhibitors during pregnancy and breastfeeding. Transl Vis Sci Technol. 2012;1(2):6.

    Article  Google Scholar 

  13. Weber-Schoendorfer C, Oppermann M, Wacker E, et al. Pregnancy outcome after TNF-α inhibitor therapy during the first trimester: a prospective multicentre cohort study. Br J Clin Pharmacol. 2015;80(4):727–39.

    Article  CAS  Google Scholar 

  14. Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. J Rheumatol. 2006;33(5):1014–7.

    PubMed  Google Scholar 

  15. Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FBA. Safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. J Rheumatol. 2009;36(3):635–41.

    Article  Google Scholar 

  16. Gottlieb AB, Blauvelt A, Thaçi D, et al. Certolizumab pegol for the treatment of chronic plaque psoriasis: results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2). J Am Acad Dermatol. 2018;79(2):302–314.e6.

    Article  CAS  Google Scholar 

  17. Lebwohl M, Blauvelt A, Paul C, et al. Certolizumab pegol for the treatment of chronic plaque psoriasis: results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT). J Am Acad Dermatol. 2018;79(2):266–276.e5.

    Article  CAS  Google Scholar 

  18. Mariette X, Förger F, Abraham B, et al. Lack of placental transfer of certolizumab pegol during pregnancy: results from CRIB, a prospective, postmarketing, pharmacokinetic study. Ann Rheum Dis. 2018;77(2):228–33.

    Article  CAS  Google Scholar 

  19. Clowse MEB, Schuerele AE, Chambers C, et al. Pregnancy outcomes after exposure to certolizumab pegol: updated results from a pharmacovigilance safety database. Arthritis Rheumatol. 2018;70:1399–407.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical College of Georgia, Augusta University, Augusta, GA, USA

    Deeti J. Pithadia

  2. University of Cincinnati, College of Medicine, Cincinnati, OH, USA

    Kelly A. Reynolds

  3. Founder and CEO, Dermatology Research and Education Foundation, Irvine, CA, USA

    Jashin J. Wu

Authors
  1. Deeti J. Pithadia
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelly A. Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jashin J. Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Founder and CEO, Dermatology Research and Education Foundation, Irvine, CA, USA

    Jashin J. Wu

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pithadia, D.J., Reynolds, K.A., Wu, J.J. (2019). 26-Year-Old Female with Worsening Psoriasis Who Is Planning Pregnancy. In: Wu, J. (eds) Clinical Cases in Psoriasis. Clinical Cases in Dermatology. Springer, Cham. https://doi.org/10.1007/978-3-030-18772-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-18772-9_12

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-18771-2

  • Online ISBN: 978-3-030-18772-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation